PreveCeutical Medical Inc. (PREV.CN)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -9856.00 CAD | 0.35% |
| 2022 | -9891.00 CAD | -94.28% |
| 2021 | -5091.00 CAD | 93.23% |
| 2020 | -75.16 Thousand CAD | -3437.7% |
| 2019 | 2252.00 CAD | -79.01% |
| 2018 | 10.72 Thousand CAD | -24.97% |
| 2017 | 14.29 Thousand CAD | 791.44% |
| 2016 | -2068.00 CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -2499.00 CAD | -2.0% |
| 2024 Q2 | -2522.00 CAD | -0.92% |
| 2023 Q4 | -2450.00 CAD | -0.57% |
| 2023 Q3 | -2436.00 CAD | 1.81% |
| 2023 Q1 | -2489.00 CAD | 62.14% |
| 2023 FY | -9856.00 CAD | 0.35% |
| 2023 Q2 | -2481.00 CAD | 0.32% |
| 2022 Q1 | -1126.00 CAD | -60.4% |
| 2022 Q3 | -1086.00 CAD | 1.72% |
| 2022 Q4 | -6574.00 CAD | -505.34% |
| 2022 Q2 | -1105.00 CAD | 1.87% |
| 2022 FY | -9891.00 CAD | -94.28% |
| 2021 FY | -5091.00 CAD | 93.23% |
| 2021 Q1 | -1530.00 CAD | 0.0% |
| 2021 Q4 | -702.00 CAD | 48.38% |
| 2021 Q3 | -1360.00 CAD | 9.21% |
| 2021 Q2 | -1498.00 CAD | 2.09% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 FY | -75.16 Thousand CAD | -3437.7% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 100.0% |
| 2019 Q2 | -16.00 CAD | -100.71% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q1 | 2268.00 CAD | 625.0% |
| 2019 FY | 2252.00 CAD | -79.01% |
| 2018 Q1 | 1140.00 CAD | -65.77% |
| 2018 FY | 10.72 Thousand CAD | -24.97% |
| 2018 Q4 | -432.00 CAD | -209.09% |
| 2018 Q3 | 396.00 CAD | -95.89% |
| 2018 Q2 | 9626.00 CAD | 744.39% |
| 2017 Q1 | -11.27 Thousand CAD | 27.85% |
| 2017 Q2 | 4248.00 CAD | 137.67% |
| 2017 Q3 | 7300.00 CAD | 71.85% |
| 2017 FY | 14.29 Thousand CAD | 791.44% |
| 2017 Q4 | 3330.00 CAD | -54.38% |
| 2016 Q3 | -8138.00 CAD | -229.21% |
| 2016 Q1 | -1319.00 CAD | 0.0% |
| 2016 Q2 | -2472.00 CAD | -87.41% |
| 2016 FY | -2068.00 CAD | 0.0% |
| 2016 Q4 | -15.62 Thousand CAD | -92.04% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -50.39 Thousand CAD | 80.444% |
| Asep Medical Holdings Inc | -113.74 Thousand CAD | 91.335% |
| BetterLife Pharma Inc. | - CAD | Infinity% |
| BioVaxys Technology Corp. | - CAD | Infinity% |
| ChitogenX Inc. | -42 Thousand CAD | 76.533% |
| Rapid Dose Therapeutics Corp. | 563.4 Thousand CAD | 101.749% |
| Defence Therapeutics Inc. | -90.92 Thousand CAD | 89.16% |
| Entheon Biomedical Corp. | 250.32 Thousand CAD | 103.937% |
| Gemina Laboratories Ltd. | -93.36 Thousand CAD | 89.444% |
| Glow Lifetech Corp. | -505.62 Thousand CAD | 98.051% |
| Lexston Life Sciences Corp. | -26.39 Thousand CAD | 62.658% |
| Pharmala Biotech Holdings Inc. | 454.09 Thousand CAD | 102.17% |
| Doseology Sciences Inc. | -36.08 Thousand CAD | 72.686% |
| MYND Life Sciences Inc. | -332.99 Thousand CAD | 97.04% |
| Nova Mentis Life Science Corp. | 25.4 Thousand CAD | 138.796% |
| PharmaTher Holdings Ltd. | -711.00 CAD | -1286.217% |
| Telescope Innovations Corp. | 595.39 Thousand CAD | 101.655% |